Case Report: Infantile Urticaria as a Herald of Neonatal Onset Multisystem Inflammatory Disease With a Novel Mutation in NLRP3

Abstract

Neonatal multisystem onset inflammatory disorder (NOMID) is a severe autoinflammatory syndrome that can have an initial presentation as infantile urticaria. Thus, an immediate recognition of the clinical symptoms is essential for obtaining a genetic diagnosis and initiation of early therapies to prevent morbidity and mortality. Herein, we describe a neonate presenting with urticaria and systemic inflammation within hours after birth who developed arthropathy and neurologic findings. Pathologic evaluation of the skin revealed an infiltration of lymphocytes, eosinophils, and scattered neutrophils. Genetic analysis identified a novel heterozygous germline variant of unknown significance in the NLRP3 gene, causing the missense mutation M408T. Variants of unknown significance are common in genetic sequencing studies and are diagnostically challenging. Functional studies of the M408T variant demonstrated enhanced formation and activity of the NLRP3 inflammasome, with increased cleavage of the inflammatory cytokine IL-1β. Upon initiation of IL-1 pathway blockade, the infant had a robust response and improvement in clinical and laboratory findings. Our experimental data support that this novel variant in NLRP3 is causal for this infant’s diagnosis of NOMID. Rapid assessment of infantile urticaria with biopsy and genetic diagnosis led to early recognition and targeted anti-cytokine therapy. This observation expands the NOMID-causing variants in NLRP3 and underscores the role of genetic sequencing in rapidly identifying and treating autoinflammatory disease in infants. In addition, these findings highlight the importance of establishing the functional impact of variants of unknown significance, and the impact this knowledge may have on therapeutic decision making.

The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China

“…Cryopyrin-associated periodic syndrome (CAPS) comprises a group of disorders with overlapping symptoms such as fever, urticarial rash, arthralgia, arthritis, and elevated acute-phase reactants (1)(2)(3). Previously, CAPS was classified into three subtypes according to distinct clinical characteristics.…”

Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicism

“…Currently, the diagnostic awareness of CAPS is increasing, and there are reports of newborns and infants successfully diagnosed and treated (13)(14)(15). However, the rate of misdiagnosis before the results of genetic testing could be considerable (14).…”

Partnerships in the Comprehensive Management of Multisystem Inflammatory Syndrome in Neonates (MIS-N): Translating 2 Years of Pediatric Practice to the Neonatal Wards

“…On January 18, 2022, more than 50 cases of MIS-N have been described (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). As in older infants and children, the lack of a diagnostic test makes the clinical diagnosis challenging in non specific cases.…”

“…Till January 18, 2022, more than 50 cases of MIS-N have been reported. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] As in older infants and children, the lack of a diagnostic test makes the clinical diagnosis challenging in non-specific cases. This may be specifically applicable to newborns and preterm ones as well, where there is a wide differential diagnosis of cases with acutely worsening conditions.…”

“…Increase in the occurrence of multisystem inflammatory syndrome in neonates (MIS-N) has been reported within the last few months, [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] including a recent case report describing a newborn with acute respiratory distress syndrome intubated on day 1 of life and diagnosed with possible MIS-N on day 4, treated with intravenous immunoglobulins (IVIGs) and steroids. The newborn also developed encephalopathy and severe endotheliitis of coronary arteries.…”